Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00245271 · ClinicalTrials.gov registry record · Phase 3
Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction
A Phase 3 study of Anterior Cruciate Ligament Reconstruction, sponsored by Omeros Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 480
- Enrollment target
- 10
- Study locations
NCT00245271: Completed Phase 3 study of Anterior Cruciate Ligament Reconstruction, sponsored by Omeros Corporation.
NCT00245271 is a Phase 3 study of Anterior Cruciate Ligament Reconstruction that has completed, run by Omeros Corporation. The registered enrollment target is 480 participants, above the 251-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (91% higher). The trial reports 10 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00245271, a Phase 3 study of Anterior Cruciate Ligament Reconstruction, has completed, sponsored by Omeros Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 480 participants
- Enrollment target
- 10
- Study locations
Study Summary
OMS103HP is being developed for improvement in knee function following ACL reconstruction. Secondary benefits being evaluated include reduced postoperative pain, improvement in knee motion and earlier return to work.
Conditions Studied
Interventions
- DRUG Vehicle
- DRUG OMS103HP
Study Locations (10)
California
- Kerlan-Jobe Orthopaedic Clinic - Los Angeles
- Sports, Orthopedic and Rehabilitation Medicine Associates (S.O.A.R.) - Redwood City
Colorado
- Advanced Orthopedic and Sports Medicine Specialists - Denver
- Colorado Orthopedic Consultants, PC - Englewood
North Carolina
- Duke University - Durham
- Wake Forest University Health Sciences - Winston-Salem
Pennsylvania
- Temple University Orthopedics - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Illinois
- Rush University - Chicago
Ohio
- Ohio State University Sports Medicine - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2004-10 |
| Est. Completion | 2011-03 |
| Phase | Phase 3 |
What the finished NCT00245271 record still lists
NCT00245271 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, above the 251-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (91% higher).
The record links to 1 condition, with Anterior Cruciate Ligament Reconstruction appearing as the primary indexed condition, and to 2 interventions - of which Vehicle is the first listed.
NCT00245271 lists 10 locations in 6 states (California, Colorado, North Carolina).
Frequently Asked Questions
What is clinical trial NCT00245271 about?
NCT00245271 is a clinical study titled "Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction". OMS103HP is being developed for improvement in knee function following ACL reconstruction. Secondary benefits being evaluated include reduced postoperative pain, improvement in knee motion and earlier return to work.
What is the current status of trial NCT00245271?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 480 participants. The study started on 2004-10. Estimated completion is 2011-03.
What conditions does trial NCT00245271 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction.
What interventions are being tested in trial NCT00245271?
The interventions under investigation include: Vehicle (DRUG), OMS103HP (DRUG).
Who is sponsoring clinical trial NCT00245271?
This trial is sponsored by Omeros Corporation, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00245271 being conducted?
This trial has 10 study locations across California, Colorado, Illinois, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00245271's enrollment target sits among peer trials
480 3rd of 11 higher than 9 of 11 other Anterior Cruciate Ligament Reconstruction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Reconstruction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
RECRUITING · Phase 2
-
Mental Imagery to Improve Quadriceps Strength Post Anterior Cruciate Ligament Reconstruction: a Feasibility Study
RECRUITING · NA
-
Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
RECRUITING · Phase 4
-
Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells
RECRUITING · Phase 1
-
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
RECRUITING · NA
-
Immunometabolic Mechanisms of Blood Flow Restriction (BFR) Training After Anterior Cruciate Ligament Reconstruction
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia